AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Revenio Group Oyj

Director's Dealing Aug 14, 2024

3236_dirs_2024-08-14_1bf91d76-401a-4ce5-aea4-c85a13fee6f8.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Revenio Group Corporation: Managers' Transactions – Kate Taylor

Revenio Group Corporation | Stock Exchange Release | August 14, 2024 at 16:00:00 EEST

Person subject to the notification requirement Name: Kate Taylor Position: Other senior manager

Issuer: Revenio Group Oyj LEI: 743700I27E0FWSXLKK04 Notification type: INITIAL NOTIFICATION Reference number: 74370/5/4

Transaction date: 2024-08-13 Outside a trading venue Instrument type: SHARE ISIN: FI0009010912 Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details (1): Volume: 333 Unit price: 0 EUR

Aggregated transactions (1): Volume: 333 Volume weighted average price: 0 EUR

For further information, please contact

CFO Robin Pulkkinen, tel. +358 50 505 9932 [email protected]

Distribution Nasdaq Helsinki FIN-FSA Key media www.reveniogroup.fi/en

Revenio Group in brief

Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand.

In 2023, the Group's net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments

Revenio Group Corporation: Managers' Transactions – Kate Taylor

Talk to a Data Expert

Have a question? We'll get back to you promptly.